HH
EDIT icon

Hilltop Holdings’s Editas Medicine EDIT Stock Holding History

Hilltop Holdings’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-2,950
Closed -$207K – 531
2020
Q4 		$207K Buy
+2,950
New +$121K 0.03% 465
2018
Q2 		– Sell
-13,845
Closed -$459K – 428
2018
Q1 		$459K Buy
+13,845
New +$493K 0.08% 239

Other funds holding EDIT

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Hilltop Holdings's EDIT Position: Q1 2021 in Review

Hilltop Holdings sold out of Editas Medicine (EDIT) in Q1 2021, closing a stake of 2,950 shares — an estimated $207K sold.

Hilltop Holdings first reported a position in EDIT in Q1 2018 and held it in 2 quarters. The position peaked at $459K in Q1 2018. 312 funds tracked by Wall St. Rank hold EDIT as of Q1 2021.

  • Hilltop Holdings reported no remaining Editas Medicine position as of Q1 2021 after selling out during the quarter.
  • Hilltop Holdings sold 2,950 Editas Medicine shares in Q1 2021, an estimated $207K.
  • Hilltop Holdings first reported a position in Editas Medicine in Q1 2018 and held it in 2 quarters.
  • Hilltop Holdings's Editas Medicine position peaked at $459K in Q1 2018.
  • 312 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2021.

Based on Hilltop Holdings's 13F filing for Q1 2021, filed 17 May 2021.